| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9005171 | Clinical Therapeutics | 2005 | 14 Pages |
Abstract
In this population of patients with OA of the knee, lumiracoxib 100 mg QD was of similar efficacy to celecoxib 200 mg QD and had similar tolerability to placebo.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
MD Sheldon, MD Beaulieu, MD Paster, MS, RPh Dutta, PhD Yu, MD Sloan,